nadla / iStockphoto.com
Big data presents an array of opportunities for the pharmaceutical industry, but companies must be careful who they partner with, said Myra McCormack, associate patent counsel at Johnson & Johnson, yesterday.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
J&J, Johnson & Johnson, big data, Myra McCormack, pharmaceuticals, 2018 AIPPI World Congress, Peter Damerell, Powell Gilbert, Martin Klok